Loading patent…
AssigneeBlis Technologies Limited
InventorsNicola Jones, John David Hale, John Tagg, Rohit Jain, Liam Karl Harold
Estimating the term…
Described herein is a method of improving the inhibitory profile of Streptococcus salivarius comprising formulating the S. salivarius in a composition comprising an effective amount of a supplemental saccharide. Also described herein are compositions comprising Streptococcus salivarius and supplemental saccharide, methods of inhibiting microorganisms using such compositions, therapeutic formulations comprising such compositions, and methods of treating or preventing diseases using such compositions and therapeutic formulations.
A method of improving the inhibitory profile of Streptococcus salivarius comprising formulating the S. salivarius in a composition comprising an effective amount of a supplemental saccharide,
A method for upregulating one or more genes in Streptococcus salivarius, comprising formulating the S. salivarius in a composition comprising an effective amount of a supplemental saccharide,
A method for increasing production of one or more of a lantiobiotic peptide, bacteriocin or urease by Streptococcus salivarius, comprising formulating the S. salivarius in a composition comprising an effective amount of a supplemental saccharide,
A method of inhibiting a skin, dental, oral, mucosal and/or ENTR microorganism, the method comprising contacting the microorganism with a composition comprising Streptococcus salivarius and an effective amount of a supplemental saccharide,
A composition comprising Streptococcus salivarius and an effective amount of a supplemental saccharide for use in improving the inhibitory profile of the Streptococcus salivarius,
A composition comprising Streptococcus salivarius K12, and raffinose in an amount of 2 to 3% by weight.
A composition comprising Streptococcus salivarius K12, and galactose in an amount of 0.25 to 0.75% by weight.
A composition comprising Streptococcus salivarius M18, and raffinose in an amount of 2 to 3% by weight.
A composition comprising Streptococcus salivarius M18, and galactose in an amount of 0.25 to 0.75% by weight.
A composition comprising Streptococcus salivarius K12, Streptococcus salivarius M18, and raffinose in an amount of 2 to 3% by weight.
A composition comprising Streptococcus salivarius K12, Streptococcus salivarius M18, and galactose in an amount of 0.25 to 0.75% by weight.
A composition comprising Streptococcus salivarius K12, Streptococcus salivarius M18, raffinose in an amount of 2 to 3% by weight, and galactose in an amount of 0.25 to 0.75% by weight.
A composition comprising Streptococcus salivarius K12, raffinose in an amount of 1.2 to 2.2% by weight, and galactose in an amount of 0.7 to 1.7% by weight.
A composition comprising Streptococcus salivarius M18, raffinose in an amount of 1.2 to 2.2% by weight, and galactose in an amount of 0.7 to 1.7% by weight.
A composition comprising Streptococcus salivarius K12, Streptococcus salivarius M18, raffinose in an amount of 1.2 to 2.2% by weight, and galactose in an amount of 0.7 to 1.7% by weight.
Use of Streptococcus salivarius and a supplemental saccharide in the manufacture of a medicament for:
A composition comprising Streptococcus salivarius and an effective amount of a supplemental saccharide for use in:
A method of manufacturing a composition comprising Streptococcus salivarius and an effective amount of a supplemental saccharide, the method comprising:
Dependencies are inferred from the claim text.